Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Form Health vs Midi Health

Form Health
Graded #317

Higher grade

vs+4.200000000000003
Midi Health
Graded #413

Lower grade

The verdict

Form Health takes it — 60.6/100 to 56.4/100.

Form Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMidi Health +16
29
45
Dose & formulationForm Health +37
77
40
Clinical oversightForm Health +8
86
78
Labs & monitoringEven
52
52
FulfillmentForm Health +3
81
78
Contract termsMidi Health +14
41
55
Form Health · left barMidi Health · right bar

The numbers

MetricForm HealthMidi Health
WeighScore60.6/10056.4/100
GradeCC
Scorecard rank#317#413
Semaglutide$1,350/mo (starting dose, brand-name)Not disclosed
Tirzepatide$1,350/mo (starting dose, brand-name)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Form Health

Graded #317 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Brand-name FDA-approved medications

Where it loses points

  • Higher brand-name pricing only
  • Premium pricing relative to market
Midi Health

Graded #413 · C

Strengths

  • Available in all 50 states
  • Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
  • Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
  • Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)

Where it loses points

  • Does not accept Medicare, Medicaid, or Medi-Cal
  • GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
  • Menopause-focused — not the right fit for men or younger women whose main goal is weight loss

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard